We are seeking a strategic and collaborative Associate Director of Medical Omnichannel & Digital Engagement to help lead and execute a Global Omnichannel Communication Strategy for therapeutic areas within the Alnylam portfolio. Reporting to the Director of Medical Omnichannel & Digital Engagement, this role is critical in supporting Alnylam’s medical digital ecosystem to impact proper channel orchestration of key medical activities.

This position is open to remote working and will be primarily located at 675 Kendall, Cambridge, MA while in the office.

Key Responsibilities:

• Support the development of a Global Omnichannel Communication Strategy for therapeutic areas within the Alnylam portfolio (commercial and pipeline) to impact optimized channel orchestration of key medical activities
• Work with multiple stakeholders in a highly matrixed environment, closely interacting with key functional groups such as Digital Marketing, Strategic Technologies, Medical Director Office, Scientific Communications, Field Medical, Legal/Regulatory/Compliance, etc.
• Partner with Global and Regional teams across therapeutic areas to advocate for omnichannel capabilities, frameworks, methodologies, and develop use cases to optimize HCP engagement experience
• Apply project management expertise to ensure timely and effective implementation of key omnichannel deliverables
• Create business case, design, and lead proof of concept/pilots for emerging digital capabilities and enhancements within Alnylam’s medical digital ecosystem
• Drive the evolution of our medical affairs website, implementing data-driven insights to enhance user experience and engagement
• Leverage Veeva Vault to optimize medical communication strategies and digital channel orchestration
• Conduct advanced data analysis and insights-driven decision-making to inform digital omnichannel strategy and channel optimization
• Implement and manage vendor relationships for digital platforms, maintenance of medical affairs website, and content management systems
• Troubleshoot roadblocks and identify creative and compliant solutions to facilitate progress of new initiatives
• Stay at the forefront of emerging omnichannel trends, medical digital channel developments, and innovative engagement opportunities within Medical Affairs
• Translate analytics results into strategic actionable insights and recommendations for enhancing channel effectiveness and omnichannel campaign performance

Qualifications:

• Doctorate degree (MD, PharmD, PhD) with a strong scientific background and minimum of 5+ years of relevant work experience
• Strong knowledge and hands-on experience of multichannel and/or omnichannel strategy execution
• Collaborative mindset with a passion for cross-functional teamwork and an open-minded approach to solving complex challenges
• Builds strong relationships to enable higher performance
• Demonstrated experience with start-to-finish planning/executing multichannel digital tactics (i.e. CRM programs, websites, email, emerging media tactics, SEO/SEM, social media)
• Ability to work on and lead independent initiatives without day-to-day supervision
• Strategic thinking with a focus on digital innovation and change management
• Commitment to continuous learning and adaptation with a results-oriented mindset
• Advanced project management skills with high emotional intelligence and ability to influence and lead (without authority) in matrix organized structure
• Experience in working for or with a digital agency is desired/preferred
• Technology-savvy with advanced proficiency in data analytics (i.e. PowerBI, GA4, Snowflake) is desired/preferred
• Proven expertise in key platforms such as Veeva Vault, Google Analytics (GA4), Web dev is desired/preferred

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.